Extramural Funding

FOUNDATION OPPORTUNITIES

Pilot Grants to Explore the Use of the American Heart Association Protein Binding Atlas to Discover Novel Protein Interactions supports innovative pilot projects aimed at predicting and understanding protein-protein and protein-small molecule interactions involved in key biological processes associated with cardiovascular, kidney, and metabolic diseases, including obesity. Application Deadline: May 1, 2025

The Mark Foundation for Cancer Research Emerging Leader Award Program is now accepting letters of intent. These $750,000 three-year grants support early career investigators in high-impact, high-risk projects distinct from their current research portfolio. This is a two-phase application process. Following the letter of intent submission and foundation review, select applicants will then be invited to submit a full proposal. Letter of Intent Due Date: May 5, 2025, 5pm Eastern

Asthma and Allergic Diseases Cooperative Research Centers (U19 CT Optional) supports multidisciplinary, human subjects research on these conditions of interest: immunopathology of asthma, allergic and non-allergic rhinitis, chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy.

If interested, contact the Office of Research Development no later than April 30, 2025.

Time-Sensitive Evaluation of Policies Affecting Health Behaviors and Chronic Disease Risk (R01 CT Not Allowed) establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program likely to influence diet, physical activity, sleep, ad/or weight thus holding the potential to lower rates of chronic diseases, particularly in populations at risk for health disparities. 2025 Application Due Dates: May 9, June 10, July 9, August 7, September 9, October 9, November 7, December 9

The New Investigator Gateway Awards for Collaborative T1D Research (R03 CT Not Allowed) promote extramural basic and clinical biomedical research improving the understanding of the mechanisms underlying disease leading to improved preventions, diagnosis, and treatment of diabetes, digestive, and kidney diseases. Letter of Intent Due Dates: May 26, 2025, and February 6, 2026

The Ethical, Legal, and Social Implications Exploratory/Developmental Research Grant (R21 CT Optional) solicits applications for research projects that identify, examine, and address the ethical, legal, and social implications of advances in genomics for individuals, families, communities, groups, institutions, and society. 2025 Application Due Dates: June 17 and October 20

The NCI Pathway to Independence Award (K99/R00 CT Req.) is designed for candidates proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial as part of their research and career development. If you are not planning on any of these, consider applying to this companion opportunity. 2025 Application Due Dates: June 17 and October 15

The NEI Clinical Research Study Planning Grant Program (R34 CT Not Allowed) supports timely planning activities and development of all materials required for the implementation of a future clinical study concerning eye and vision research. 2025 Application Due Dates: June 16 and October 16

If interested in Congressionally Directed Medical Research Programs,  the Office of Research Development encourages you to visit the subject area pages for the most up-to-date information as some funding opportunities are currently open while others are simply anticipated. Should you have any questions about these or other opportunities, please reach out to ORD.

LOI Deadline: 30 days before the application due date.

Application Due Date(s): August 6, 2025; August 6, 2026